Effect of fludarabine on leukocyte functions

Chemotherapy

Volumn 50, Issue 6, 2004, Pages 283-288

  Doǧan, A Lale ^a   Doǧan, Ayça ^a   Canpinar, Hande ^a   Düzgünçinar, Övünç ^a   Demirpençe, Ediz ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Apoptosis; Degranulation; Fludarabine; Hypochlorous acid; Myeloperoxidase; Neutrophils

Indexed keywords

FLUDARABINE; MYELOPEROXIDASE;

ARTICLE; CELL STRAIN HL 60; CONCENTRATION RESPONSE; CONTROLLED STUDY; DEGRANULATION; DRUG EFFECT; ENZYME ACTIVITY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LEUKOCYTE FUNCTION; PRIORITY JOURNAL; SPECTROPHOTOMETRY; TIME;

ANTINEOPLASTIC AGENTS; CELL CULTURE TECHNIQUES; CELL DEGRANULATION; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; FLOW CYTOMETRY; HL-60 CELLS; HUMANS; HYPOCHLOROUS ACID; NEUTROPHILS; PEROXIDASE; VIDARABINE;

EID: 11244250728     PISSN: 00093157     EISSN: None     Source Type: Journal    
DOI: 10.1159/000082627     Document Type: Article

References (28)

1. Rai KR, Döhner H, Keating MJ, Montserrat E: Chronic lymphocytic leukemia: Case-based session. Hematology (Am Soc Hematol Educ Program) 2001, pp 140-156.
2. Schriever F, Huhn D: New directions in the diagnosis and treatment of chronic lymphocytic leukaemia. Drugs 2003;63:953-969.
3. Johnson SA: Clinical pharmacokinetics of nucleoside analogs: Focus on haematological malignancies. Clin Pharmacokinet 2000;39:5-26.
4. Gandhi V, Plunkett W: Cellular and clinical pharmacology of fludarabine. Clin Pharmacokinet 2002;41:93-103.
5. Sampath D, Plunkett W: The role of c-jun kinase in the apoptotic response to nucleoside analogue-induced DNA damage. Cancer Res 2000;60:6408-6415.
6. Sanhes L, Tang R, Delmer A, DeCaprio JA, Ajchenbaum-Cymbalista F: Fludarabine-induced apoptosis of B chronic lymphocytic leukemia cells includes early cleavage of p27kip1 by caspases. Leukemia 2003;17:1104-1111.
7. Babior BM: Phagocytes and oxidative stress. Am J Med 2000;109:33-44.
8. Hampton MB, Kettle AJ, Winterbourn CC: Inside the neutrophil phagosome: Oxidants, myeloperoxidase, and bacterial killing. Blood 1998;92:3007-3017.
9. Carr AC, Hawkins CL, Thomas SR, Stocker R, Frei B: Relative reactivities of N-chloramines and hypochlorous acid with human plasma constituents. Free Radic Biol Med 2001;30:526-536.
10. Miller RA, Britigan BE: Role of oxidants in microbial pathophysiology. Clin Microbiol Rev 1997;10:1-18.
11. Pullar JM, Vissers MC, Winterbourn CC: Living with a killer: The effects of hypochlorous acid on mammalian cells. IUBMB Life 2000;50:259-266.
12. Campling BG, Pym J, Galbraith PR, Cole SPC: Use of the MTT assay for rapid determination of chemosensitivity of human leukemic blast cells. Leuk Res 1988;12:823-831.
13. Hansen MB, Nielsen SE, Berg K: Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J Immunol Methods 1989;119:203-210.
14. Ulukaya E, Colakogullari M, Wood EJ: Interference by anti-cancer chemotherapeutic agents in the MTT-chemosensitivity assay. Chemotherapy 2004;50:43-50.
15. Gerber CE, Kuçi S, Zipfel M, Niethammer D, Bruchelt G: Phagocytic activity and oxidative burst of granulocytes in persons with myeloperoxidase deficiency. Eur J Clin Chem Clin Biochem 1996;34:901-908.
16. Suzuki K, Ota H, Sasagawa S, Sakatani T, Fujikura T: Assay method for myeloperoxidase in human polymorphonuclear leukocytes. Anal Biochem 1983;132:345-352.
17. Kettle AJ, Winterbourn CC: Assays for the chlorination activity of myeloperoxidase. Methods Enzymol 1994;233:502-512.
18. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-254.
19. Morabito F, Stelitano C, Callea I, Dattola A, Console G, Pucci G, Iacopino P, Callea V, Di Raimondo F, Brugiatelli M: In vitro drug-induced cytotoxicity predicts clinical response to fludarabine in B-cell chronic lymphocytic leukaemia. Br J Haematol 1998;102:528-531.
20. Drexler HG, Quentmeier H, MacLeod RAF, Uphoff CC, Hu ZB: Leukemia cell lines: In vitro models for the study of acute promyelocytic leukemia. Leuk Res 1995;19:681-691.
21. Akbiyik F, Demirpence E, Kuzu MA, Kilinc K: In vitro and in vivo inhibition of myeloperoxidase by 5-fluorouracil. Eur J Clin Pharmacol 2001;57:631-636.
22. Goodman ER, Fiedor PS, Fein S, Athan E, Hardy MA: Fludarabine phosphate: A DNA synthesis inhibitor with potent immunosuppressive activity and minimal toxicity. Am Surg 1996;435-442.
23. Adalati R, Gurer US, Cevikbas A, Johansson C: In vitro effect of amikacin, imipenem, cefodizime, IFNα-2a alone and combinations of antibiotics with IFNα-2a on polymorphonuclear leukocyte function in chronic hepatitis patients. Chemotherapy 2001;47:261-265.
24. Kim R, Tanabe K, Uchida Y, Emi M, Inoue H, Toge T: Current status of the molecular mechanisms of anticancer drug-induced apoptosis. Cancer Chemother Pharmacol 2002;50:343-352.
25. 2-induced apoptosis of HL60 human leukemia cells. J Biol Chem 2000;275:22461-22469.
26. Wagner BA, Britigan BE, Reszka KJ, McCormick ML, Burns CP: Hydrogen peroxide-induced apoptosis of HL60 human leukemia cells is mediated by the oxidants hypochlorous acid and chloramines. Arch Biochem Biophys 2002;401:223-234.
27. Tsurubuchi T, Aratani Y, Maeda N, Koyama H: Retardation of early-onset PMA-induced apoptosis in mouse neutrophils deficient in myeloperoxidase. J Leukoc Biol 2001;70:52-58.
28. Lin KM, Austin GE: Functional activity of three distinct myeloperoxidase (MPO) promoters in human myeloid cells. Leukemia 2002;16:1143-1153.